The Lancet Oncology is an authoritative forum for key opinion leaders across medicine, government, and health systems to influence
clinical practice, explore global policy, and inform constructive, positive change worldwide.
As the global leader in clinical oncology
research, The Lancet Oncology delivers essential original research, expert review, candid commentary, and breaking news to provide
context and perspective on today's most important medical advances across the broad spectrum of oncology.
The Lancet Oncology is stringently edited and peer-reviewed to ensure the scientific merit and clinical relevance of its
diverse content. All original research is Fast Tracked to publication within 8 weeks of submission and published Online First on thelancet.com
before the print issue. Articles published in the journal regularly receive coverage in the mainstream print, online, and broadcast media.
Visit http://www.TheLancet.comwww.TheLancet.com to find out more about The Lancet Oncology.
